Last reviewed · How we verify
Intensified Treatment With Carfilzomib in Myeloma Patients Still PET-positive After First Line Treatment. (CONPET)
A PET-CT will be performed on patients with myeloma after a standard first-line treatment. The PET-positive patients will receive 4 cycles of Carfilzomb-Revlimid-Dexamethason (KRd), before a new PET-CT will be performed.
Details
| Lead sponsor | Oslo University Hospital |
|---|---|
| Phase | PHASE2 |
| Status | ACTIVE_NOT_RECRUITING |
| Enrolment | 53 |
| Start date | Fri Mar 16 2018 00:00:00 GMT+0000 (Coordinated Universal Time) |
| Completion | Sun Nov 01 2026 00:00:00 GMT+0000 (Coordinated Universal Time) |
Conditions
- Myeloma
Interventions
- Carfilzomib
- Lenalidomide
- PET-CT
- Dexamethasone
Countries
Denmark, Sweden, Norway